
Aktiviere Job-Benachrichtigungen per E-Mail!
Erstelle in nur wenigen Minuten einen maßgeschneiderten Lebenslauf
Überzeuge Recruiter und verdiene mehr Geld. Mehr erfahren
A biopharmaceutical firm in Zug is looking for a Senior Manager, Market Research & Competitive Insights to lead international market research initiatives. The role involves collaborating with commercial and medical teams to drive research efforts, particularly focusing on AYVAKYT in systemic mastocytosis. Ideal candidates will have over 7 years of relevant experience in pharmaceutical market research, strong analytical skills, and fluency in English, alongside project management capabilities. This role offers an office-based position in alignment with a flexible work model.
Level of position: Senior Manager
Position type: Office-based, in alignment with BlueFlex model*
How will your role help us transform hope into reality?
The Senior Manager, Int’l Market Research & Competitive Insights leads market research and competitive intelligence activities across Blueprint Medicines’ International Direct Markets (EU4+UK and select Western European countries). This role focuses primarily on AYVAKYT in systemic mastocytosis and may expand to support future allergy and inflammation pipeline assets.
As a strategic partner to International Commercial, Medical, Access, and Country Commercial teams, this role delivers actionable insights that shape commercial strategy and guide decision‑making.
At Blueprint Medicines, we achieve impactful results because of our global crew of compassionate innovators – the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action, we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights, which drives our success.
This is the place where the extraordinary becomes reality, and you could be part of it.
Patients are waiting. Are you ready to make the leap?
Blueprint Medicines, a Sanofi company, is a global biopharmaceutical company that seeks to improve and extend patients' lives by solving important medical problems, with a focus on allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a track record of success, leveraging our established research, development, and commercial capability and infrastructure, we aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases and solid tumors. For more information, visit www.BlueprintMedicines.com and follow us on X (formerly Twitter; @BlueprintMeds) and LinkedIn.
*Blueflex is our operating model which optimizes culture, productivity, & flexibility by maximizing the critical strengths of in‑person work with the benefits of added flexibility. Blueflex allows for mix of in‑office and remote work, enables flexibility to meet individual and business needs and makes effective use of our facilities and resources. It is a culture enhancer.